Burcon Announces Board Change and Confirms No Material Undisclosed Information
December 08 2017 - 12:48PM
Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon” or
the “Corporation”), announced that effective today, Mr. Matthew
Hall has resigned as a director of the Corporation. As
previously announced on September 8, 2017, Mr. Hall received more
votes withheld than votes in favour of his election as a director
at the Corporation’s annual and special meeting held on September
7, 2017. In accordance with the Corporation’s majority
voting policy, Mr. Hall was required to submit his resignation to
the board of directors for its consideration. After due
consideration, the Board decided to accept his resignation.
“Mr. Hall has made significant contributions to Burcon during
his tenure as a director and as chair of the nominating and
compensation committee. The board of directors is grateful
for his guidance and leadership over the years,” said Dr. Allan
Yap, Chairman and Chief Executive Officer of Burcon.
The nominating and compensation committee is in the process of
assessing its governance needs and identifying a new independent
director for the Corporation.
At the request of IIROC on behalf of the Toronto Stock Exchange,
Burcon also confirms that it is not aware of any material
undisclosed information relating to the Corporation that may be
contributing to the recent increase in market price and level of
trading activity of its shares.
About Burcon NutraScience Corporation
Burcon is a leader in developing functionally and nutritionally
valuable plant-based proteins. The company has developed a
portfolio of composition, application, and process patents
originating from a core protein extraction and purification
technology. Burcon’s CLARISOY™ soy protein offers clarity and
high-quality protein nutrition for low pH beverage systems and
excellent solubility and exceptionally clean flavor at any pH;
Peazazz® is a uniquely soluble and clean-tasting pea protein; and
Puratein®, Supertein® and Nutratein® are canola protein isolates
with unique functional and nutritional attributes. For more
information about the company, visit www.burcon.ca.
The TSX has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements or forward-looking information within the meaning of the
U.S. Private Securities Litigation Reform Act of 1995 and
applicable Canadian securities legislation. Forward-looking
statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from
those expressed or implied by such forward-looking statements.
Forward- looking statements or forward-looking information can be
identified by words such as “anticipate,” “intend,” “plan,” “goal,”
“project,” “estimate,” “expect,” “believe”, “future,” “likely,”
“may,” “should,” “could”, “will” and similar references to future
periods. All statements other than statements of historical fact
included in this release are forward-looking statements, including,
without limitation, statements regarding expectations, intentions
and plans contained in this press release. There can be no
assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those
anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon’s
plans and expectations include the actual results of business
negotiations, marketing activities, adverse general economic,
market or business conditions, regulatory changes and other risks
and factors detailed herein and from time to time in the filings
made by Burcon with securities regulators and stock exchanges,
including in the section entitled “Risk Factors” in Burcon’s annual
information form dated June 21, 2017 filed with the Canadian
securities administrators on www.sedar.com and contained in
Burcon’s 20-F filed with the U.S. Securities and Exchange
Commission on www.sec.gov. Any forward-looking statement or
information only speaks as of the date on which it was made and,
except as may be required by applicable securities laws, Burcon
disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Although Burcon believes that the assumptions inherent
in the forward-looking statements are reasonable, forward-looking
statements are not guarantees of future performance, and
accordingly, investors should not rely on such statements.
CLARISOY is a trademark of Archer Daniels
Midland Company.
Media & Industry Contact:Paul LamManager,
Business DevelopmentBurcon NutraScience CorporationTel (604)
733-0896, Toll-free (888) 408-7960plam@burcon.ca
www.burcon.ca
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jul 2023 to Jul 2024